Less than four years after returning to Bausch + Lomb to lead the eye health company following its split from Bausch Health, ...

Bausch + Lomb said on Monday that CEO Brent Saunders will depart the company after a mutual ​agreement with the board, and the eye-care company's ‌Chairman Thomas Appio will take on the role on an ...

Bausch and Brent Saunders “mutually agreed” on his exit from the company, according to a statement. Elsewhere, Tezspire could have a new edge on Dupixent and a recent buyout deal paid dividends.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...